SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-305424
Filing Date
2018-10-23
Accepted
2018-10-23 17:12:27
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d629458d424b5.htm 424B5 503456
2 GRAPHIC g629458g08c20.jpg GRAPHIC 36896
  Complete submission text file 0001193125-18-305424.txt   555298
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-221972 | Film No.: 181134701
SIC: 2836 Biological Products, (No Diagnostic Substances)